Steven Nissen
Get to know Steven Nissen, the cardiologist who raised worries about Vioxx and Avandia.

Nissen, Steven, M.D.
Chairman, Department of Cardiovascular Medicine
Immediate Past President, American College of Cardiology, Washington, DC
| appointed: | 1992 |
| medical school: | University of Michigan Medical School Ann Arbor, MI |
| specialty training: | Fellowship - University of Kentucky Chandler Medical Center Lexington KY Internship - University of California Davis Medical Center Sacramento CA Residency - University of California Davis Medical Center Sacramento CA |
| other education: | B.S. - University of Michigan Ann Arbor MI |
| specialty interests: | intravascular ultrasound, digital angiography and computer image processing, coronary intensive care |
Source: Cleveland Clinic
Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, Merck & Co. Inc., voluntarily pulled the drug from the market, according to new data.
From ivanhoe.com
()
- Vioxx trial data shows early cardiovascular risk (sciencedaily.com)
We have long been writing about the links between Merck’s blockbuster nonsteroidal, anti-inflammatory medication Vioxx (rofecoxib) and negative cardiac events. Now, according to Science Daily, a study has found that evidence of cardiovascular risks linked to Vioxx might have been realized almost four years before Merck & Co. Inc., pulled the drug from the market. Vioxx [...]
From personalinjurylawnews.com
()
- Vioxx risks could have been identified years earlier (latimes.com)
The risks of taking anti-inflammatory drug Vioxx could have been detected nearly four years before the drug was pulled from the market, according to analysis of nearly 30 clinical trials.The findings, published in the Archives of Internal Medicine on Monday, analyzed 30 Vioxx trials involving around 20,000 individuals and fund evidence of the drug's risks from as early as 2000.The Merck-made drug was pulled in 2004 after it was linked with...
From france24.com
()
- Merck Knew of Dangerous Vioxx Heart Risks (dbtechno.com)
- Another suit filed against GSK over Avandia in St. Clair County (feedburner.com)
It's been 5 years since the then CEO of giant drug-maker Merck, Raymond Gilmartin, testified to the US Senate Finance Committee regarding evidence showing that Vioxx increases the risk of death due to heart attacks, strokes and other cardiovascular events.
In a Summary of Prepared Testimony, Gilmartin stated that prior to the APPROVe trial (a study looking at the protective effects of Vioxx on the risk for colon cancer), the research done by...
From z.about.com
()
- Postmarketing Lessons to Learn From Vioxx Debacle (medscape.com)
CHICAGO (Reuters) - Heart risks from taking Merck & Co Inc's painkiller Vioxx could have been detected more than three years before the company withdrew the drug from the market in September 2004, had the data been openly available, U.S. researchers said on Monday.
From reuters.com
()
- Merck Loses Vioxx Hearing Bid at Canada’s Top Court (personalinjurylawnews.com)
AbbottAUSTIN (Legal Newsline)-A Texas judge has dismissed a lawsuit brought by the state attorney general against drugmaker Merck & Co. over its now-withdrawn painkiller Vioxx.In a 2005 lawsuit, Texas Attorney General Greg Abbott had sought a refund on behalf of the state for money spent on the drug. The lawsuit also sought damages and penalties for alleged violations of the Texas Medicaid Fraud Prevention Act.Travis County Judge Scott...
From feedburner.com
()
- Texas court tosses state Vioxx suit against Merck (reuters.com)
- Merck Loses Vioxx Appeal (newsinferno.com)
- Vioxx Settlement Fund Will Pay 3,000+ Death Claims (newsinferno.com)
WHITEHOUSE STATION, N.J. (AP) — Merck & Co. said Monday a district court judge in Texas dismissed all claims in a state Medicaid lawsuit over the painkiller Vioxx.Merck said Travis County, Texas District Court Judge Scott H. Jenkins granted the company's motion for summa....
From dailyreportonline.com
()
- Texas Court dismisses all claims against Merck in VIOXX-related lawsuit (News... (personalinjurylawnews.com)
If we're missing a great Steven Nissen quoye, please add it by clicking on "edit"
Steven Nissen Quotes:
“The idea that you would see such a huge benefit so quickly is hard to accept.”
“We could still be wrong. That's what has to happen for this drug to move forward.”
“This panel was asleep at the switch.”
“There's only one way: through good science.”
“Physicians ought to take this into account. These drugs are not very forgiving.”
Steven Nissen Quotes:
“The idea that you would see such a huge benefit so quickly is hard to accept.”
“We could still be wrong. That's what has to happen for this drug to move forward.”
“This panel was asleep at the switch.”
“There's only one way: through good science.”
“Physicians ought to take this into account. These drugs are not very forgiving.”



